Tuesday, December 11, 2012

• Catalyst Issues Stock to BioMarin, Celldex Reports Positive Results: Healthcare Business Updateat Wall St. Cheat Sheet (Tue, Dec 11)
• 5 Biotechs With Short Squeeze Potential Hitting New 52 Week Highsat Seeking Alpha (Tue, Dec 11)
• Celldex Therapeutics, Inc. Moving Forward With Breast Cancer Treatmentat Seeking Alpha (Tue, Dec 11)
• Stock Watch Tuesday, 11 December 2012at Seeking Alpha (Tue, Dec 11)
• Celldex says CDX-301 well-tolerated in Phase 1 multi-dose studytheflyonthewall.com (Tue, Dec 11)
• Celldex Therapeutics’ CDX-301 Safely Mobilizes Hematopoietic Cells in Phase 1 Study; Future Development PlannedBusiness Wire (Tue, Dec 11)
• Celldex Soars After Exciting Phase 2 Dataat Motley Fool (Tue, Dec 11)
• 3 Biotechs Racing Higher On Positive Developmentsat Seeking Alpha (Tue, Dec 11)

Monday, December 10, 2012

• Solid Data, More Studies Neededat Motley Fool (Mon, Dec 10)
• The Nasdaq Now: Topsy-Turvy Day of Trading for Appleat Minyanville (Mon, Dec 10)
• Celldex jumps on breast cancer drug study dataAP (Mon, Dec 10)
• Omnicare Outlook Viewed as Conservative and 4 Must-See Stock Analysesat Wall St. Cheat Sheet (Mon, Dec 10)
• Strong November lifts McDonald'soptionMONSTER (Mon, Dec 10)
• Celldex Targeted Drug Benefits Patients With Aggressive Breast Cancerat TheStreet (Mon, Dec 10)

Saturday, December 8, 2012

• Celldex Targeted Drug Benefits Patients With Aggressive Breast Cancerat TheStreet (Sat, Dec 8)
• Final Data from Celldex Therapeutic’s CDX-011 Phase 2 Study in Metastatic Breast Cancer Supports Overall Survival Benefit in Patients with High GPNMB ExpressionBusiness Wire (Sat, Dec 8)

Friday, December 7, 2012

• Celldex Therapeutics Announces Upcoming Presentation at Oppenheimer Healthcare ConferenceBusiness Wire (Fri, Dec 7)

Thursday, December 6, 2012

• Small Pharma Sector Leaders Could Make A Profitable Diversified Portfolioat Seeking Alpha (Thu, Dec 6)

Wednesday, December 5, 2012

• Celldex Therapeutics' CEO Presents at Deutsche Bank dbAccess BioFEST (Transcript)at Seeking Alpha (Wed, Dec 5)
• Improving Trend in FDA First Cycle Review Approvals a Major Factor for Biotech Industry's Success in 2012Marketwired (Wed, Dec 5)

Tuesday, December 4, 2012

• Celldex Therapeutics Announces Upcoming Data Presentations on CDX-1127 and CDX-011Business Wire (Tue, Dec 4)

Friday, November 30, 2012

• Cramer's Homework: Less Familiar Stocks, but Less Attractive?at CNBC (Fri, Nov 30)
• [video] You Ask, Cramer Answers!at CNBC (Fri, Nov 30)
• Biotech Stock Mailbag: Amicus, Celldexat TheStreet (Fri, Nov 30)
• Celldex Therapeutics Announces Upcoming Presentation at the Deutsche Bank 2012 dbAccess BioFESTBusiness Wire (Fri, Nov 30)

Add CLDX News to My Yahoo!